This company has been acquired
Paratek Pharmaceuticals Future Growth
Future criteria checks 4/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Paratek Pharmaceuticals.
Key information
73.2%
Earnings growth rate
72.9%
EPS growth rate
Pharmaceuticals earnings growth | 23.6% |
Revenue growth rate | 13.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 07 Aug 2023 |
Recent future growth updates
Recent updates
Improved Revenues Required Before Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Stock's 77% Jump Looks Justified
Apr 17Paratek Pharmaceuticals: Patience Is Wearing Thin
Aug 24Paratek Pharmaceuticals GAAP EPS of -$0.33 beats by $0.01, revenue of $29.6M beats by $0.42M
Aug 03Paratek Pharmaceuticals: A Deeply Undervalued Antibiotic Company
Jan 03The Play On Paratek Pharmaceuticals
Oct 18Peeking Back In On Paratek Pharmaceuticals
Aug 07Paratek Pharma launches Phase 2b Nuzyra study in nontuberculous mycobacterial
Jun 16Paratek shares rise after FDA approves NUZYRA oral only dosing regimen
Jun 01Paratek Offers Long-Term Value Potential In The Difficult Antibiotic Business
Apr 27Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK): Are Analysts Optimistic?
Mar 01Could The Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Ownership Structure Tell Us Something Useful?
Feb 01Paratek Pharmaceuticals secures $60M non-recourse loan for Hercules debt repayment
Jan 04Paratek Pharmaceuticals: 100%+ Upside As Nuzyra Sales Scale
Dec 01Paratek Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 221 | 2 | -9 | N/A | 2 |
12/31/2024 | 218 | -14 | 30 | N/A | 3 |
12/31/2023 | 163 | -46 | -10 | N/A | 2 |
6/30/2023 | 177 | -63 | -23 | -23 | N/A |
3/31/2023 | 167 | -66 | -36 | -36 | N/A |
12/31/2022 | 160 | -64 | -66 | -66 | N/A |
9/30/2022 | 117 | -89 | -66 | -66 | N/A |
6/30/2022 | 111 | -86 | -27 | -27 | N/A |
3/31/2022 | 139 | -59 | -46 | -46 | N/A |
12/31/2021 | 130 | -59 | -49 | -48 | N/A |
9/30/2021 | 114 | -52 | -53 | -52 | N/A |
6/30/2021 | 104 | -54 | -108 | -107 | N/A |
3/31/2021 | 55 | -87 | -95 | -95 | N/A |
12/31/2020 | 47 | -97 | -104 | -103 | N/A |
9/30/2020 | 40 | -99 | -116 | -115 | N/A |
6/30/2020 | 30 | -111 | -115 | -114 | N/A |
3/31/2020 | 23 | -121 | -129 | -129 | N/A |
12/31/2019 | 17 | -129 | -134 | -134 | N/A |
9/30/2019 | 25 | -124 | -118 | -117 | N/A |
6/30/2019 | 21 | -124 | -110 | -110 | N/A |
3/31/2019 | 19 | -120 | -98 | -98 | N/A |
12/31/2018 | 17 | -112 | -81 | -81 | N/A |
9/30/2018 | 5 | -111 | -85 | -85 | N/A |
6/30/2018 | 5 | -101 | -80 | -80 | N/A |
3/31/2018 | 13 | -89 | -73 | -73 | N/A |
12/31/2017 | 13 | -89 | -80 | -79 | N/A |
9/30/2017 | 8 | -94 | -82 | -80 | N/A |
6/30/2017 | 8 | -96 | -95 | -94 | N/A |
3/31/2017 | 0 | -108 | N/A | -101 | N/A |
12/31/2016 | 0 | -112 | N/A | -94 | N/A |
9/30/2016 | N/A | -106 | N/A | -86 | N/A |
6/30/2016 | N/A | -106 | N/A | -78 | N/A |
3/31/2016 | N/A | -91 | N/A | -70 | N/A |
12/31/2015 | N/A | -71 | N/A | -55 | N/A |
9/30/2015 | 4 | -61 | N/A | -49 | N/A |
6/30/2015 | 4 | -42 | N/A | -30 | N/A |
3/31/2015 | 4 | -29 | N/A | -18 | N/A |
12/31/2014 | 4 | -20 | N/A | -19 | N/A |
9/30/2014 | 0 | -12 | N/A | -9 | N/A |
6/30/2014 | 1 | -11 | N/A | -8 | N/A |
3/31/2014 | 0 | -11 | N/A | -8 | N/A |
12/31/2013 | 0 | -11 | N/A | -6 | N/A |
9/30/2013 | 1 | -37 | N/A | -9 | N/A |
6/30/2013 | 1 | -41 | N/A | -11 | N/A |
3/31/2013 | 3 | -45 | N/A | -10 | N/A |
12/31/2012 | 3 | -50 | N/A | -12 | N/A |
9/30/2012 | 4 | -28 | N/A | -12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PRTK is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: PRTK is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PRTK is expected to become profitable in the next 3 years.
Revenue vs Market: PRTK's revenue (13.8% per year) is forecast to grow faster than the US market (7.7% per year).
High Growth Revenue: PRTK's revenue (13.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PRTK's Return on Equity is forecast to be high in 3 years time